Physician profile

Olufemi Abiodun

Gastroenterology (Internal Medicine) · Arlington, TX

NPI 1821199464

$6,252.14

in general payments reported to CMS, 2019-2025

34 companies · $780 in 2025

The $780 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).

See the full distribution for Gastroenterology (Internal Medicine)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,196.19
Education$82.05

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $3,040.72 2019-2025 Rinvoq, Linzess, Skyrizi
Janssen Biotech, INC. $516.81 2019-2025 Stelara, Tremfya, Simponi
Takeda Pharmaceuticals U.S.A., INC. $502.44 2019-2023 Entyvio
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $337.58 2019-2023 Trulance
Gilead Sciences, INC. $202.18 2019-2023
Qol Medical, LLC $201.46 2019-2023 Sucraid
Merck Sharp & Dohme LLC $159.26 2019-2024 Dificid, Bridion
Celgene Corporation $126.98 2021-2024 Zeposia
Pinnacle Biologics, INC $115.81 2024 Photofrin
Ironwood Pharmaceuticals, INC $104.05 2020-2023 Linzess
Pfizer INC. $91.95 2021-2023
Nestle Healthcare Nutrition INC. $83.60 2021-2023
Braintree Laboratories, INC. $78.68 2020-2021
Redhill Biopharma INC. $57.72 2020-2022
Cook Medical LLC $57.07 2025 Hemospray
Show all 34 companies
CompanyGeneral paymentsYearsTop products
Vivus LLC $51.19 2021-2023 Qsymia
Regeneron Healthcare Solutions, INC. $48.32 2023-2025 Dupixent
Lilly USA, LLC $44.67 2024-2025 Omvoh
Allergan, INC. $44.15 2019-2020
Intercept Pharmaceuticals, INC. $43.12 2019-2022
Olympus America INC. $41.04 2025 Endoclot Phs
Ardelyx, INC. $40.64 2022-2023 Ibsrela
Madrigal Pharmaceuticals $39.08 2025 Rezdiffra
Boehringer Ingelheim Pharmaceuticals, INC. $38.88 2023 Cyltezo
Genzyme Corporation $31.27 2023
Shionogi INC $20.57 2020
Alexion Pharmaceuticals, INC. $20.29 2019
E.R. Squibb & Sons, L.L.C. $20.20 2021
Sandoz INC. $18.25 2024 Hyrimoz
Endo Pharmaceuticals INC. $17.33 2020
Ambu INC. $16.09 2020
Evoke Pharma, INC. $14.61 2022
Novo Nordisk INC $14.56 2025 Wegovy
Micro-Tech Endoscopy USA, INC. $11.57 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Olufemi Abiodun

$6,252.14

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbvie INC.
Context
The $780 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).

https://glasscript.com/doctor/264957/olufemi-abiodun

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.